T-cell proliferation and antitumour activities of a truncated mutant of staphylococcal enterotoxin C2 with decreased cytokine secretion

References

1. Chen T. Z. 2005; The basis and criteria for the effective dose of SEC2 oral liquid. Prog Microbiol Immunol 33:51–58
   [Google Scholar]
2. Dinges M. M., Orwin P. M., Schlievert P. M. 2000; Exotoxins of Staphylococcus aureus. Clin Microbiol Rev 13:16–34 [View Article][PubMed]
   [Google Scholar]
3. Dohlsten M., Abrahmsén L., Björk P., Lando P. A., Hedlund G., Forsberg G., Brodin T., Gascoigne N. R., Förberg C., Lind P. 1994; Monoclonal antibody–superantigen fusion proteins: tumor-specific agents for T-cell-based tumor therapy. Proc Natl Acad Sci U S A 91:8945–8949 [View Article][PubMed]
   [Google Scholar]
4. Hoffmann M. L., Jablonski L. M., Crum K. K., Hackett S. P., Chi Y.-I., Stauffacher C. V., Stevens D. L., Bohach G. A. 1994; Predictions of T-cell receptor- and major histocompatibility complex-binding sites on staphylococcal enterotoxin C1. Infect Immun 62:3396–3407[PubMed]
   [Google Scholar]
5. Hovde C. J., Hackett S. P., Bohach G. A. 1990; Nucleotide sequence of the staphylococcal enterotoxin C3 gene: sequence comparison of all three type C staphylococcal enterotoxins. Mol Gen Genet 220:329–333 [View Article][PubMed]
   [Google Scholar]
6. Letertre C., Perelle S., Dilasser F., Fach P. 2003; Identification of a new putative enterotoxin SEU encoded by the egc cluster of Staphylococcus aureus. J Appl Microbiol 95:38–43 [View Article][PubMed]
   [Google Scholar]
7. Llewelyn M., Cohen J. 2002; Superantigens: microbial agents that corrupt immunity. Lancet Infect Dis 2:156–162 [View Article][PubMed]
   [Google Scholar]
8. Mondal T. K., Bhatta D., Biswas S., Pal P. 2002; Superantigen-induced apoptotic death of tumor cells is mediated by cytotoxic lymphocytes, cytokines, and nitric oxide. Biochem Biophys Res Commun 290:1336–1342 [View Article][PubMed]
   [Google Scholar]
9. Mosmann T. 1983; Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63 [View Article][PubMed]
   [Google Scholar]
10. Müller-Alouf H., Carnoy C., Simonet M., Alouf J. E. 2001; Superantigen bacterial toxins: state of the art. Toxicon 39:1691–1701 [View Article][PubMed]
    [Google Scholar]
11. Munson S. H., Tremaine M. T., Betley M. J., Welch R. A. 1998; Identification and characterization of staphylococcal enterotoxin types G and I from Staphylococcus aureus. Infect Immun 66:3337–3348[PubMed]
    [Google Scholar]
12. Ono H. K., Omoe K., Imanishi K., Iwakabe Y., Hu D.-L., Kato H., Saito N., Nakane A., Uchiyama T., Shinagawa K. 2008; Identification and characterization of two novel staphylococcal enterotoxins, types S and T. Infect Immun 76:4999–5005 [View Article][PubMed]
    [Google Scholar]
13. Papageorgiou A. C., Baker M. D., McLeod J. D., Goda S. K., Manzotti C. N., Sansom D. M., Tranter H. S., Acharya K. R. 2004; Identification of a secondary zinc-binding site in staphylococcal enterotoxin C2. Implications for superantigen recognition. J Biol Chem 279:1297–1303 [View Article][PubMed]
    [Google Scholar]
14. Roggiani M., Stoehr J. A., Leonard B. A., Schlievert P. M. 1997; Analysis of toxicity of streptococcal pyrogenic exotoxin A mutants. Infect Immun 65:2868–2875[PubMed]
    [Google Scholar]
15. Schad E. M., Papageorgiou A. C., Svensson L. A., Acharya K. R. 1997; A structural and functional comparison of staphylococcal enterotoxins A and C2 reveals remarkable similarity and dissimilarity. J Mol Biol 269:270–280 [View Article][PubMed]
    [Google Scholar]
16. Shaw D. M., Connolly N. B., Patel P. M., Kilany S., Hedlund G., Nordle O., Forsberg G., Zweit J., Stern P. L., Hawkins R. E. 2007; A phase II study of a 5T4 oncofoetal antigen tumour-targeted superantigen (ABR-214936) therapy in patients with advanced renal cell carcinoma. Br J Cancer 96:567–574 [View Article][PubMed]
    [Google Scholar]
17. Sundstedt A., Grundström S., Dohlsten M. 1998; T cell- and perforin-dependent depletion of B cells in vivo by staphylococcal enterotoxin A. Immunology 95:76–82 [View Article][PubMed]
    [Google Scholar]
18. US Pharmacopeia 2002 The United States Pharmacopeia Rockville, MD: US Pharmacopeia Convention;
    [Google Scholar]
19. Wang X., Zhang H., Xu M., Liu C., Zhang C. 2009; Biological analysis of the deletion mutants of Staphylococcal enterotoxin C2. Appl Microbiol Biotechnol 83:1077–1084 [View Article][PubMed]
    [Google Scholar]
20. Xu M.-K., Zhang C.-G. 2006; Gene expression and function study of fusion immunotoxin anti-Her-2-scFv-SEC2 in Escherichia coli. Appl Microbiol Biotechnol 70:78–84 [View Article][PubMed]
    [Google Scholar]
21. Xu M., Wang X., Cai Y. M., Zhang H., Yang H., Liu C., Zhang C. 2011; An engineered superantigen SEC2 exhibits promising antitumor activity and low toxicity. Cancer Immunol Immunother 60:705–713 [View Article][PubMed]
    [Google Scholar]